![](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/21281275-731698894-cce415121e6b28a164c036b58e629197d7e2b12a-200x200-100x100.jpeg)
Bevacizumab Biosimilar Receives Approval in the European Union
The European Medicines Agency (EMA) has approved Avzivi (BAT1706), a biosimilar referencing bevacizumab (Avastin), according to an announcement from Bio-Thera Solutions.1 Avzivi is approved for the following indications in Europe: in combination with …